When the debt is repaid next week, Valeant will have reduced its debt by more than $6.7 billion since the end of the first quarter of 2016.. Source: BioSpace

Now insiders say J&J has decided it is no longer interested. Source: BioSpace

The company burned through $1.2B and never brought a drug to market in its 37 years. Source: BioSpace

Based in Toronto, Ontario, Fibrocor Therapeutics was launched in January 2017. Source: BioSpace

The drug is the first available FDA-approved Peptide Receptor Radionuclide Therapy. Source: BioSpace

KaNDy Therapeutics is a clinical-stage company that is focused on female sex-hormone related conditions. Source: BioSpace

Joseph Jimenez retires at the end of the month after eight years in the top job at Novartis. Source: BioSpace

Another experimental Alzheimer's disease treatment has failed in a late-stage study. Source: BioSpace

The effort was announced last week by the Henri A. Termeer Tribute Committee. Source: BioSpace

Immune-Onc Therapeutics launched in September 2016 and is headquartered in Palo Alto, California. Source: BioSpace